The FDA also required changes to the labels to achieve a more uniform presentation of side effects and risk information for all of the drugs in the GLP-1 category, including adding or changing subsections for Acute Pancreatitis and Severe Gastrointestinal Adverse Reactions and revising the Patient Counseling section and Medication Guide. Some of the labels were also updated with post-marketing reports of hair loss (alopecia) and the neurological symptom of altered sense of touch, or dysethesia
55 (4): 1177-1185.Reference Source Heerding JM, Moore HW
Common experiences: slight increase in dream vividness, minor changes in sleep timing, occasional earlier awakening The first noticeable improvements often appear during this window
At 24 weeks, the mean relative change from baseline in liver fat was a 42.9% reduction in the 1 mg group, a 57.0% reduction at 4 mg, an 81.4% reduction at 8 mg, and an 82.4% reduction at the 12 mg dose
Because it is mixed in a pharmacy rather than a factory, there can be slight variations in the inactive ingredients
R., Boehles, H., Das, A., Haase, C., Hennermann, J